| Not Yet Recruiting | Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus NCT02664740 | Centre Hospitalier Universitaire de Nīmes | Phase 1 / Phase 2 |
| Recruiting | Modeling Host-Pathogen Interaction Using Lymphoid Organoids NCT06479837 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Recruiting | Unbound Cloxacillin Concentrations During Continuous Infusion NCT06848387 | Emeli Månsson | Phase 4 |
| Completed | Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends NCT07013864 | Centre Hospitalier de Saint-Denis | — |
| Recruiting | Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial NCT05899140 | Frieder Schaumburg | Phase 4 |
| Completed | Staphylococcus Lugdunensis Prosthetic Joint Infection NCT04409392 | Hospices Civils de Lyon | — |
| Completed | Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal In NCT03915470 | Destiny Pharma Plc | Phase 2 |
| Unknown | Ceftriaxone as Home IV for Staph Infections NCT04141787 | Vancouver Island Health Authority | Phase 4 |
| Unknown | Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China NCT03456544 | Peking University First Hospital | — |
| Completed | Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections NCT02782078 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryn NCT02595112 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults NCT02492958 | Pfizer | Phase 2 |
| Completed | Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscop NCT02502474 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Ag NCT02364596 | Pfizer | Phase 1 |
| Completed | Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus NCT01643941 | Pfizer | Phase 1 |
| Unknown | Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection NCT01144000 | Andrej Trampuz | Phase 2 |
| Completed | Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections NCT02640937 | BG Unfallklinik Murnau | — |
| Completed | Bacterial Phenotype of Staphylococcus Aureus Has no Effect on Patients' Clinical Outcome in Orthopedic Device NCT02971657 | BG Unfallklinik Murnau | — |
| Completed | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care NCT01431326 | Daniel Benjamin | — |
| Completed | Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Heal NCT02557568 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine NCT01447407 | NovaDigm Therapeutics, Inc. | Phase 1 |
| Completed | Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureu NCT01364571 | Pfizer | Phase 1 |
| Completed | Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida NCT01273922 | NovaDigm Therapeutics, Inc. | Phase 1 |
| Terminated | Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized A NCT01196169 | Mountain Home Research & Education Corporation | Phase 4 |
| Completed | An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults NCT01018641 | Pfizer | Phase 1 |
| Completed | Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colon NCT00859677 | Henry M. Jackson Foundation for the Advancement of Military Medicine | — |
| Withdrawn | A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis NCT00509847 | AM-Pharma | Phase 1 / Phase 2 |
| Completed | What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Prese NCT00736554 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | — |
| Completed | Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicil NCT00779246 | Christiana Care Health Services | N/A |
| Completed | Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections NCT00427076 | Rabin Medical Center | Phase 3 |
| Completed | Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons NCT00631566 | Henry M. Jackson Foundation for the Advancement of Military Medicine | N/A |
| Completed | Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan) NCT00666276 | Pfizer | — |
| Completed | Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection NCT00419991 | CPL Associates | Phase 4 |
| Completed | Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With o NCT01324440 | Merck Sharp & Dohme LLC | Phase 1 |
| Unknown | Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant NCT00518076 | University of Sao Paulo | — |
| Completed | Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis NCT00620984 | State University of New York - Upstate Medical University | — |
| Unknown | A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely NCT00368498 | National Taiwan University Hospital | Phase 4 |
| Unknown | Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Ar NCT00423982 | Oslo University Hospital | Phase 4 |
| Completed | V710 First-In-Man (FIM) Study (V710-001) NCT00303069 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Inf NCT00501150 | Imperial College London | N/A |
| Terminated | Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease NCT00130260 | Nabi Biopharmaceuticals | Phase 3 |
| Completed | StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery NCT00211965 | Nabi Biopharmaceuticals | Phase 3 |
| Completed | Evaluation of Consistency of StaphVAX Manufacturing Lots NCT00211991 | Nabi Biopharmaceuticals | Phase 3 |
| Completed | Preventing Staphylococcal (Staph) Infection NCT00108160 | US Department of Veterans Affairs | Phase 4 |
| Completed | Evaluation of Manufacturing Lot of StaphVAX NCT00211900 | Nabi Biopharmaceuticals | Phase 3 |
| Completed | StaphVAX Immunogenicity in Orthopedic Implant Patients NCT00211926 | Nabi Biopharmaceuticals | Phase 3 |
| Completed | StaphVAX in Cardiovascular Surgery Patients NCT00211913 | Nabi Biopharmaceuticals | Phase 3 |
| Completed | Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature In NCT00113191 | Bristol-Myers Squibb | N/A |
| Completed | Aurograb and Vancomycin in MRSA Infection NCT00217841 | NeuTec Pharma | Phase 3 |
| Completed | Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis NCT00071214 | Nabi Biopharmaceuticals | Phase 3 |
| Completed | Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight- NCT00066989 | Nabi Biopharmaceuticals | Phase 2 |
| Completed | Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections NCT00156377 | University Hospital Muenster | Phase 4 |
| Completed | Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Ba NCT00063089 | Nabi Biopharmaceuticals | Phase 1 / Phase 2 |
| Completed | Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococ NCT00175370 | University of British Columbia | N/A |
| Unknown | Preoperative Nasal Swabs From Pediatric Patients NCT00646919 | Hillel Yaffe Medical Center | — |